This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

4 Stocks With Upgrades: XRX, DRB, CLI, STR

Stocks in this article: XRX DLB CLI STR

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Dolby Laboratories

The entertainment products provider announced on Tuesday that it sued ArcSoft, one of its licensees, for not meeting contractual obligations.

"DLB announced today that it is increasing its stock repurchase program by an additional $100 million, bringing the approximate amount available for future repurchases of Dolby's Class A Common Stock to $436 million," Collins Stewart analysts wrote in a Feb. 8 report. They added, "Due to the increased stock repurchase program, we are raising our 2012 EPS ests from $2.54 to $2.56 vs. consensus ests of $2.54. Additionally, we are raising our 2013 EPS ests from $2.39 to $2.43 vs. consensus ests of $2.46."

Dolby Laboratories was upgraded to buy from hold by TheStreet Ratings.

"The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and notable return on equity," TheStreet Ratings wrote. "We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself."

Dolby Laboratories has a forward P/E of 13.94; the average for broadcasting and entertainment companies is 14.43. For comparison, Sirius (SIRI) and Cablevision (CVC) have forward P/Es of 22.29 and 12.52, respectively.

Seven of the 13 analysts who cover Dolby Laboratories rated it a hold; the other six gave it a buy rating.

TheStreet Ratings gives Dolby Laboratories a B grade with a $43.15 price target. The stock closed Wednesday at $38.09 and has increased 24.84% year to date.

Mack-Cali Realty

The real estate investment trust reported last week fourth-quarter earnings of $16.1 million, or 18 cents a share, an increase from year-earlier earnings of $6.6 million, or 9 cents.

"While the suburban office markets remain challenging for any landlord, CLI continues to execute, maintaining occupancy levels well above market averages," Keefe, Bruyette & Woods analysts wrote in a Feb. 9 report. "With its fortress-like balance sheet (debt to mkt cap 42%) and premium yield (6.2%), we believe CLI has defensive attributes in a difficult environment."

Shares of Mack-Cali were upgraded to buy from hold by TheStreet Ratings.

Mack-Cali has a forward P/E of 37.13; the average for industrial and office REITs is 70.75. For comparison, Vornado Realty Trust (VNO) and Boston Properties (BXP) both have higher forward P/Es of 41.22 and 61.73, respectively.

Of the 13 analysts who cover Mack-Cali, seven rated it a hold. Three analysts gave it a buy rating and another three rated it a sell.

TheStreet Ratings gives Mack-Cali a B- grade with a $33.07 price target. The stock closed Wednesday at $28.59 and has risen 7.12% year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

2 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs